Obicetrapib and its Impurities

Obicetrapib is a new investigational cholesterol-lowering drug that works by inhibiting CETP, helping to reduce LDL and increase HDL levels. Reference standards of Obicetrapib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.